Sponsor
Stephen F. Lynch
Representative · D-MA
Representative · D-MA
The bill strengthens U.S. defense readiness and supply-chain resilience by creating regular coordination and targeted reviews (including a biomanufacturing reserve analysis), but it increases administrative complexity and costs, may advantage certain industries through a broad technology definition, and delays immediate fixes to urgent biodefense gaps.
Federal agencies, defense planners, and technology experts will coordinate more regularly and gain a dedicated Subcommittee on Emerging Technology, improving the government's ability to identify and prioritize critical technologies (AI, semiconductors, biotech) for national defense and supply-chain resilience.
Federal planners, healthcare systems, and the military will get a mandated analysis of building a U.S. biomanufacturing reserve, which should clarify what capacities are needed, strengthen pandemic/biothreat preparedness, and guide targeted investments.
Authorizing subcommittees and focused reviews to address cross‑agency supply chain gaps and innovation bottlenecks can improve industrial efficiency and domestic production resilience and help guide investment in emerging biomanufacturing technologies.
Taxpayers and federal budgets will face higher costs from new administrative layers, required studies, and the potential future expense of building and maintaining a biomanufacturing reserve identified as necessary for defense.
More frequent meetings and new subcommittees plus the staffing needed to conduct evaluations will impose time burdens on agency staff and external participants (scientists, industry), diverting attention from other work and increasing administrative costs.
A broad, flexible definition of 'covered technology' risks expanding industrial policy or creating preferences for certain firms, which could distort competition and affect small businesses' access to DPA tools.
Based on analysis of 4 sections of legislative text.
Creates a DPA Subcommittee on Emerging Technology, requires regular DPA Committee meetings, and mandates an 18‑month study on a strategic biomanufacturing reserve.
Official title: To amend the Defense Production Act of 1950 to modify the requirements of the Defense Production Act Committee, establish a Subcommittee on Emerging Technology, and for other purposes.
Introduced March 24, 2026 by Stephen F. Lynch · Last progress March 24, 2026
Creates a permanent Subcommittee on Emerging Technology within the Defense Production Act (DPA) Committee, requires that the DPA Committee meet regularly and allows the Chairperson to form subcommittees, and directs the new Subcommittee to define “covered technology” (suggesting AI, biotech, semiconductors, quantum, etc.). The Subcommittee must deliver to Congress within 18 months an evaluation of establishing a strategic biomanufacturing reserve to meet national defense needs. A minor punctuation correction to the DPA short-title citation is also made, effective on enactment.